Skip to main content

Advertisement

Open Peer Review Reports for: Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
20 Feb 2003 Submitted Original manuscript
6 Mar 2003 Reviewed Reviewer Report - Rolf van Heeswijk
18 Mar 2003 Reviewed Reviewer Report - Leslie Huson
18 Apr 2003 Author responded Author comments - Keith Pappa
Resubmission - Version 2
18 Apr 2003 Submitted Manuscript version 2
29 Apr 2003 Reviewed Reviewer Report - Leslie Huson
30 Apr 2003 Reviewed Reviewer Report - Rolf van Heeswijk
16 May 2003 Author responded Author comments - Keith Pappa
Resubmission - Version 3
16 May 2003 Submitted Manuscript version 3
Publishing
10 Jun 2003 Editorially accepted
10 Jun 2003 Article published 10.1186/1471-2334-3-10

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement